Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Despite the low positive rate of the high-throughput screening (0.013%), a series of less potent hit molecules were identified
To enhance the pharmacological properties of the ruthenium catalyst, provide cancer selectivity for the treatment, and enable the treatment of challenging hypoxic tumors, the metal complexes were covalently conjugated to the side chains of polymers with a carbon fluorinated moiety that could co-deliver oxygen to the tumor
A typical tapering protocol might reduce your dose by 25% every 23 weeks
The main problem, according to unanimous opinion, is the formation of oxygen radicals (ROS) and the oxidative stress in skin cells which is dramatically increased by PM
